Efficacy and Safety of Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma : a Prospective, Single Arm and Multicenter Trial
Latest Information Update: 04 Aug 2023
At a glance
- Drugs Surufatinib (Primary) ; Toripalimab (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 13 Jul 2021 New trial record